Role and mechanism of PTEN in Burkitt's lymphomaChuntuan Li, Xiongpeng Zhu|Oncology Reports|2020Cited by 7
Results of a registrational Phase 2 study of lisaftoclax monotherapy for treatment of patients (pts) with Relapsed/Refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who had failed Bruton's tyrosine kinase inhibitors (BTKis)Keshu Zhou, Jianyong Li, Jie Jin et al.|Blood|2025Cited by 0